Artal Group »

Newamsterdam Pharma Co Nv shares owned by Artal Group

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Artal Group from 13F filings

Historical chart of Artal Group investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Artal Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Artal Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $19M 800k 23.65

More positions owned by Artal Group

Cava Group Ord (CAVA)
Lexicon Pharmaceuticals Com New (LXRX)
Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Arrowhead Pharmaceuticals Call Option (ARWR)
Morphic Hldg (MORF)
Apellis Pharmaceuticals (APLS)
Springworks Therapeutics (SWTX)
Crinetics Pharmaceuticals In (CRNX)
Beigene Sponsored Adr (BGNE)
Silence Therapeutics Ads (SLN)
Dyne Therapeutics (DYN)
Revolution Medicines (RVMD)
Kura Oncology (KURA)
Neumora Therapeutics (NMRA)

View all positions for Artal Group

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
Viking Global Investors
RA Capital Management
Medicxi Ventures Management
Adage Capital Partners GP
BVF
Cormorant Asset Management
Goldman Sachs Group
Millennium Management
GMT Capital Corp
Jennison Associates
Artal Group
Deerfield Management Company

View all funds holding Newamsterdam Pharma Co Nv